Search

everythinglearnresearchcommunity

for

Search:↓

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

The treatment was effective and tolerable for advanced gastric cancer.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

The combination therapy was effective and well-tolerated, especially in young patients.

Promising cancer treatments were found, but the manufacturer closed.

Most patients experienced significant but reversible hair loss during treatment.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Biological therapy boosts the immune system to effectively fight melanoma.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

The combination treatment showed a higher response rate but no significant survival benefits.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Trastuzumab may cause tufted hair folliculitis as a side effect.